Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Dopamine Receptor
    (1)
  • Endogenous Metabolite
    (1)
  • Phospholipase
    (1)
  • Serine Protease
    (1)
  • Others
    (2)
TargetMol | Tags By ResearchField
  • Cardiovascular System
    (2)
  • Cancer
    (1)
  • Nervous System
    (1)
Filter
Search Result
Results for "

movas

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    3
    TargetMol | All_Pathways
  • Halopemide
    T1546159831-65-1In house
    Halopemide is a potent inhibitor of PLD (IC50 = 220 and 310 nM for human PLD1 and PLD2). Halopemid is an antagonist of dopamine receptors. Halopemid can be used in psychotropic research.
    • $29
    In Stock
    Size
    QTY
  • STOCK2S-26016
    WNK-IN-B, WNK IN B, Compound B
    T29161332922-63-1
    WNK-IN-B is an inhibitor of Wnk signalling. WNK-IN-B is a cell-permeable diaminoacridine derivative that targets the CCT domain of SPAK and OSR1 via reversible binding. WNK-IN-B selectively suppress hypotonic shock-induced WNK signaling pathway activation
    • $1,470
    6-8 weeks
    Size
    QTY
  • 2,3-Diphospho-D-glyceric acid pentasodium salt
    2,3-DPG pentasodium salt
    T83406102783-53-9
    2,3-Diphospho-D-glyceric acid pentasodium salt is a highly anionic polyphosphorus compound located within the concave center of red blood cells, where it decreases oxygen affinity by binding to hemoglobin. This endogenous compound selectively inhibits vascular calcification (VC) and effectively postpones the formation of crystalline calpain particles (CPP). Additionally, it inhibits calcification in the mouse vascular smooth muscle cell line (MOVAS) without eliciting cytotoxic effects [1].
    • Inquiry Price
    8-10 weeks
    Size
    QTY